Sky Century Investment (SKYI) Receivables - Other (2013 - 2014)

Sky Century Investment's (SKYI) quarterly Receivables - Other came in at -$40195.0 in Q3 2014, down 55.61% on a QoQ basis from -$25830.0 in Q2 2014.

Sky Century Investment (SKYI) Receivables - Other (2013 - 2014) Analysis & Trends

Sky Century Investment (SKYI) has 2 years of Receivables - Other data on file, last reported at -$40195.0 in Q3 2014.

On a quarterly basis, Receivables - Other changed N/A year-over-year to -$40195.0 in Q3 2014; TTM through Aug 2014 was -$40195.0, a N/A change from a year earlier, with the FY2014 full-year figure at -$31765.0, down 129.42% from the prior year.
Receivables - Other for Q3 2014 stood at -$40195.0, down from -$25830.0 in the prior quarter.
Over the last five years, Receivables - Other for SKYI reached as high as -$13846.0 in Q2 2013 and fell as low as -$40195.0 in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Sky Century Investment	1.06 Mn	1.06 Mn	26,045.00

Download Data